| Mrs Ushma Patel, MD | |
|
617 23rd Street, Medical Plaza A Suite 8b, Ashland, KY 41101-2845 | |
| (606) 408-7246 | |
| (606) 408-7230 |
| Full Name | Mrs Ushma Patel |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 26 Years |
| Location | 617 23rd Street, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043322175 | NPI | - | NPPES |
| 64109796 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 39645 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters' Medical Center | Ashland, KY | Hospital |
| Kings Daughters Medical Center Ohio | Portsmouth, OH | Hospital |
| Southern Ohio Medical Center | Portsmouth, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ashland Physiatry And Pain Management | 7517997166 | 2 |
News Archive
Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest "premalignant" genetic changes that mark the potential onset of the most common and deadliest form of disease.
Giselle Aerni, MD presented her research project "The Effect of Lace-Up Ankle Bracing on Knee Biomechanics During a Jump Landing" at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, GA on April 24, 2012.
Today, a clinician can order a blood test to check a patient's cholesterol or hemoglobin A1c levels - biomarkers that help predict an individual's risk of cardiovascular disease or diabetes, respectively. But despite decades of advances in the understanding of Alzheimer's disease (AD), a blood test for predicting its risk remains elusive.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
› Verified 1 days ago
| Entity Name | Ashland Physiatry & Pain Management |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588865398 PECOS PAC ID: 7517997166 Enrollment ID: O20050815000317 |
News Archive
Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest "premalignant" genetic changes that mark the potential onset of the most common and deadliest form of disease.
Giselle Aerni, MD presented her research project "The Effect of Lace-Up Ankle Bracing on Knee Biomechanics During a Jump Landing" at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, GA on April 24, 2012.
Today, a clinician can order a blood test to check a patient's cholesterol or hemoglobin A1c levels - biomarkers that help predict an individual's risk of cardiovascular disease or diabetes, respectively. But despite decades of advances in the understanding of Alzheimer's disease (AD), a blood test for predicting its risk remains elusive.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
› Verified 1 days ago
| Entity Name | Ashland Integrative Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982099438 PECOS PAC ID: 3173844289 Enrollment ID: O20150601002860 |
News Archive
Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest "premalignant" genetic changes that mark the potential onset of the most common and deadliest form of disease.
Giselle Aerni, MD presented her research project "The Effect of Lace-Up Ankle Bracing on Knee Biomechanics During a Jump Landing" at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, GA on April 24, 2012.
Today, a clinician can order a blood test to check a patient's cholesterol or hemoglobin A1c levels - biomarkers that help predict an individual's risk of cardiovascular disease or diabetes, respectively. But despite decades of advances in the understanding of Alzheimer's disease (AD), a blood test for predicting its risk remains elusive.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ushma Patel, MD Po Box 1378, Ashland, KY 41105-1378 Ph: (606) 408-7246 | Mrs Ushma Patel, MD 617 23rd Street, Medical Plaza A Suite 8b, Ashland, KY 41101-2845 Ph: (606) 408-7246 |
News Archive
Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest "premalignant" genetic changes that mark the potential onset of the most common and deadliest form of disease.
Giselle Aerni, MD presented her research project "The Effect of Lace-Up Ankle Bracing on Knee Biomechanics During a Jump Landing" at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, GA on April 24, 2012.
Today, a clinician can order a blood test to check a patient's cholesterol or hemoglobin A1c levels - biomarkers that help predict an individual's risk of cardiovascular disease or diabetes, respectively. But despite decades of advances in the understanding of Alzheimer's disease (AD), a blood test for predicting its risk remains elusive.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
› Verified 1 days ago
Dr. Dhruv Pandya, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 617 23rd Street, Suite 8b, Medical Plaza A, Ashland, KY 41101 Phone: 606-408-7246 Fax: 606-408-7230 | |
Mr. Harry Jules Bell, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1101 Saint Christopher Dr, Ste. 200, Ashland, KY 41101 Phone: 606-324-4102 Fax: 606-327-5625 |